• 4 months ago
Over nine million doses of Covid-19 vaccines procured during the pandemic by the Malaysian government expired as of June 2024, which resulted in a RM185mil loss for the government, says Datuk Seri Dr Dzulkefly Ahmad.

The Health Minister told the Dewan Rakyat during Ministers' Question Time on Thursday (July 11) that the expired vaccines comprised around 10.8% of Malaysia's overall procured vaccine doses during the pandemic which totaled 84.5mil doses as of February 2021.

Read more at https://tinyurl.com/382yvukn

WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline

Category

🗞
News
Transcript
00:00For your information, since the COVID-19 immunization program started on February 24, 2021,
00:14the Malaysian government has received 84.5 million doses of the COVID-19 vaccine,
00:21both from procurement and from donations.
00:25As of 11 June 2024, there are 9,159,151 doses of the COVID-19 vaccine in the vaccine stock
00:35that has been distributed in the KKM facilities and in our warehouses.
00:44The procurement and distribution process is carried out in accordance with the asset and stock management procedures.
01:05There is also a second question, which is a bit confusing, but I will remind myself.
01:11The White House spokesman said,
01:14hindsight is always perfect, vision 2020.
01:17On the question of how much loss, I do not mean to be negative towards predecessors or Ministers in my view.
01:27Moreover, this question is rarely answered by Ministers on the matter of contractual NDA obligations.
01:34I am willing to give this answer.
01:37More or less, what we bear in terms of loss is RM185 million, equivalent of USD40 million.
01:48This also includes things related to logistics, logistics in terms of storage, storage and so on.
01:59So, to sum up, the question is for the previous Ministers,
02:08they do not have anything that is said to be SOPs, best practices or benchmarking,
02:16because that is the pandemic for the first time.
02:19So, with that, I understand that even if there is an advantage,
02:24it is related to the competition to get vaccine procurement, which is very tough.
02:29So, the question of how, the advantages and so on,
02:32after we face this pandemic for the first time,
02:36we have a little bit of SOPs and best practices for the coming pandemic.
02:42Thank you.

Recommended